Methergine
NDC 66336-402
Product Information
Methergine is a NDA-approved product labeled by Dispensing Solutions, Inc.. This medication is used after childbirth to help stop bleeding from the uterus. It is supplied as a purple product. This product entry covers the primary NDC 66336-402 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
78;54;SANZOZ
Code Structure Chart
Product Details
What is NDC 66336-402?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- METHYLERGONOVINE MALEATE (UNII: IR84JPZ1RK)
- METHYLERGONOVINE (UNII: W53L6FE61V) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACACIA (UNII: 5C5403N26O)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- D&C RED NO. 7 (UNII: ECW0LZ41X8)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- GELATIN (UNII: 2G86QN327L)
- LACTOSE (UNII: J2B2A4N98G)
- MALEIC ACID (UNII: 91XW058U2C)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- POVIDONE (UNII: FZ989GH94E)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- STARCH, CORN (UNII: O8232NY3SJ)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- SUCROSE (UNII: C151H8M554)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- METHYLPARABEN (UNII: A2I8C7HI9T)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 996824 - methylergonovine maleate 0.2 MG Oral Tablet
- RxCUI: 996826 - methergine 0.2 MG Oral Tablet
- RxCUI: 996826 - methylergonovine maleate 0.2 MG Oral Tablet [Methergine]
- RxCUI: 996826 - Methergine 0.2 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.